Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study

Description

The Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study is a cross-consortium project generating harmonized datasets from diverse human cohorts. It provides post-mortem multi-omic data from more than 850 individuals representing the spectrum of Alzheimer's disease phenotypes, with substantial representation of Black or African American and Hispanic or Latino individuals. Data were generated by research teams at Rush University, Emory University, Mayo Clinic, Columbia University, and the Icahn School of Medicine at Mount Sinai.

Update Frequency

AD Knowledge Portal Data Releases are published monthly (https://news.adknowledgeportal.org/). Updates to specific studies are dependent on data contributor and ingress timelines.

License

https://adknowledgeportal.synapse.org/Explore/Studies/DetailsPage/StudyDetails?Study=syn51732482#Acknowledgement

Documentation

https://doi.org/10.7303/9618093

Managed By

Sage Bionetworks

See all datasets managed by Sage Bionetworks.

Contact

https://www.synapse.org/Synapse:syn2580853/discussion/default

How to Cite

Accelerating Medicines Partnership Alzheimer's Disease (AMP-AD) Diverse Cohorts Study was accessed on DATE from https://registry.opendata.aws/amp-ad-diverse-cohorts. The results published here are in whole or in part based on data obtained from the AD Knowledge Portal (NIH-NIA, U24AG061340).

Usage Examples

Publications

• Bridging the gap: Multi-omics profiling of brain tissue in Alzheimer's disease and older controls in multi-ethnic populations by Reddy JS, Heath L, Vander Linden A, Allen M, Lopes KDP, Seifar F, et al.